CYTOKINETICS INC — Director's Dealing 2020

Oct 6, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2020-10-05

Reporting Person: Kaye Edward M. MD (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-10-05	Common Stock	M	20000	$7.61	Acquired	20000	Direct
2020-10-05	Common Stock	S	20000	$30.0	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-05	Non-Qualified Stock Option (right to buy)	$7.61	M	20000	Disposed	2026-05-18	Common Stock (20000)	Direct

Footnotes

F1: Transaction effected pursuant to a 10b5-1 plan entered into by the Reporting Person on May 13, 2020.